Randall Schatzman
29Patents
8h-index
19Co-inventors
72Inventor score
Filing activity: Aug 27, 1997 → Mar 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7906117B2 | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever | Chemistry; Metallurgy | 53 | Active |
| US8268582B2 | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | Chemistry; Metallurgy | 49 | Active |
| US8337847B2 | Methods of treating anemia using anti-IL-6 antibodies | Emerging Cross-Sectional Technologies | 48 | Active |
| US7927863B2 | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | Chemistry; Metallurgy | 29 | Active |
| US9452227B2 | Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments | Emerging Cross-Sectional Technologies | 22 | Active |
| US6284732A | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases | Human Necessities | 12 | Expired |
| US6391852B1 | Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases | Human Necessities | 12 | Expired |
| US9724410B2 | Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity | Emerging Cross-Sectional Technologies | 8 | Active |
| US9775921B2 | Subcutaneously administrable composition containing anti-IL-6 antibody | Emerging Cross-Sectional Technologies | 7 | Active |
| US9187560B2 | Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever | Emerging Cross-Sectional Technologies | 6 | Active |
| US9821057B2 | Anti-IL-6 antibody for use in the treatment of cachexia | Emerging Cross-Sectional Technologies | 6 | Active |
| US7119170B2 | Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases | Human Necessities | 5 | Expired |
| US9546213B2 | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever | Chemistry; Metallurgy | 5 | Active |
| US10053506B2 | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever | Emerging Cross-Sectional Technologies | 4 | Active |
| US10391169B2 | Method of treating allergic asthma with antibodies to IL-6 | Emerging Cross-Sectional Technologies | 2 | Active |
| US10117955B2 | Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies | Emerging Cross-Sectional Technologies | 2 | Active |
| US10640560B2 | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or fever | Emerging Cross-Sectional Technologies | 2 | Active |
| US10160804B2 | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever | Chemistry; Metallurgy | 2 | Active |
| US9873746B2 | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | Chemistry; Metallurgy | 1 | Active |
| US8709756B2 | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | Chemistry; Metallurgy | 1 | Active |
| US10259883B2 | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | Chemistry; Metallurgy | 1 | Active |
| US6924265B2 | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases | Human Necessities | 1 | Expired |
| US7374892B2 | Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases | Human Necessities | 0 | Active |
| US7374765B2 | Methods and compositions for diagnosis and treatment of iron misregulation diseases | Human Necessities | 0 | Expired |
| US7329650B2 | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.